Table 4.
Study (N) | CIN definition | Acetylcysteine | Control | P value |
---|---|---|---|---|
Azmus [77] (397) | ≥25% or ≥0.5 mg/dL, increase in SCr at 48 hours | 7.1 | 8.4 | .62 |
Boccalandro [81] (179) | ≥0.5 mg/dL increase in SCr at 48 hours | 13 | 12 | .84 |
Briguori [82] (183) | ≥25% increase in Scr at 48 hours | 65 | 11 | .22 |
Kay [79] (200) | ≥25% increase in SCr at 48 hours | 4 | 12 | .03 |
Marenzi [78] (354) | ≥25% increase in SCr at 72 hours | 15 versus 8a | 30 | <.001 |
Webb [80] (487) | >5 mL/min decrease in CrCl | 23.3 | 20.7 | .57 |
CIN, contrast-induced nephropathy; CrCl. Creatinine clearance; IV, intravenous; SCr, serum creatinine, dd, double dose
aThree arm study: standard dose versus high dose versus placebo.